Articles from Investor's Business Daily

Reddit's huge success since its IPO in March last year is driven by earnings and revenue gains, earning it a terrific 98 Composite Rating.
Via Investor's Business Daily · February 7, 2025

Trump tariff news, earnings and economics are creating market uncertainty. Jeffrey Hirsch explains how traders should react.
Via Investor's Business Daily · February 7, 2025

The Relative Strength (RS) Rating for ZEEKR Intelligent stock entered a new percentile Friday, with a rise from 69 to 80.
Via Investor's Business Daily · February 7, 2025

On Friday, Lincoln National stock reached a key technical benchmark, seeing its RS Rating jump to 81, up from 67 the day before.
Via Investor's Business Daily · February 7, 2025

On Friday, freight transportation XPO stock received a positive adjustment to its Relative Strength (RS) Rating, from 69 to 80.
Via Investor's Business Daily · February 7, 2025

Uber stock gained for a second straight day as Bill Ackman said he had built a stake worth more than $2 billion.
Via Investor's Business Daily · February 7, 2025

Shares rocketed on Friday, but the company might not be out of hot water yet.
Via Investor's Business Daily · February 7, 2025

EXPE stock received price target hikes.
Via Investor's Business Daily · February 7, 2025

Kimbal Musk sold $27 million worth of TSLA on Thursday.
Via Investor's Business Daily · February 7, 2025

Your supervisor or client giving you a hard time? Keeping cool in tough situations at work isn't easy. But conflict resolution is vital.
Via Investor's Business Daily · February 7, 2025

Palantir led big earnings winners. Google and Amazon were losers.
Via Investor's Business Daily · February 7, 2025

Amazon stock fell on its Q4 results. The tech giant will spend $100 billion in 2025 focused on AI but said growth could be "lumpy."
Via Investor's Business Daily · February 7, 2025

Japan's SoftBank is reportedly close to becoming the biggest investor in generative artificial intelligence leader OpenAI, usurping Microsoft.
Via Investor's Business Daily · February 7, 2025

Take-Two Interactive Software delivered better-than-expected profitability and earnings guidance late Thursday. TTWO stock rose.
Via Investor's Business Daily · February 7, 2025

Today's jobs report is expected to show stable hiring and unemployment, but weather, fires and the Trump effect may surprise.
Via Investor's Business Daily · February 7, 2025

Affirm stock rose after the consumer financing firm swung to a profit in its fiscal Q2 as revenue handily beat views.
Via Investor's Business Daily · February 6, 2025

Demand for domain name registrations will be key in VeriSign's earnings report.
Via Investor's Business Daily · February 6, 2025

On Thursday, e-commerce Coupang stock had its Relative Strength (RS) Rating upgraded to 81, up from 74 a day earlier.
Via Investor's Business Daily · February 6, 2025

Leading AI chip stocks got a lift this week from hyperscale cloud computing companies reiterating their hefty data center spending plans.
Via Investor's Business Daily · February 7, 2025

Broadcom earned a berth on IBD's flagship screen of the best growth stocks to watch, one of 13 stocks rising onto various IBD watchlists.
Via Investor's Business Daily · February 6, 2025

Doximity, which ranks fifth on the IBD 50, crushed December-quarter expectations late Thursday and raised its outlook.
Via Investor's Business Daily · February 6, 2025

Fortinet stock popped on Q4 earnings that topped Wall Street estimates while 2025 revenue guidance came in well above views.
Via Investor's Business Daily · February 6, 2025

Cloudflare stock rose on Q4 earnings and revenue that topped Wall Street targets while full-year 2025 revenue guidance met views.
Via Investor's Business Daily · February 6, 2025

On Thursday, insurance Kemper stock earned an upgrade to its Relative Strength (RS) Rating to 73, up from 69 a day earlier.
Via Investor's Business Daily · February 6, 2025

Ralph Lauren stock rallied early Thursday after the luxury lifestyle retailer cleared Q3 estimates, hiked its revenue guidance
Via Investor's Business Daily · February 6, 2025

Rivian has made its commercial van available for the general public with a $79,900 price tag.
Via Investor's Business Daily · February 6, 2025

Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.
Via Investor's Business Daily · February 6, 2025

Onto Innovation stock saw a positive improvement to its Relative Strength (RS) Rating on Thursday, rising from 78 to 82.
Via Investor's Business Daily · February 6, 2025

Pinterest stock edged higher ahead of its Q4 report, which offers the social media player a chance to show progress in boosting its ad sales.
Via Investor's Business Daily · February 6, 2025

China's BYD is set to unveil driver-assist tech for the masses. Shares are soaring.
Via Investor's Business Daily · February 6, 2025

Lawmakers in Congress may ban China's DeepSeek artificial intelligence software from government devices amid national security concerns.
Via Investor's Business Daily · February 6, 2025

Peloton earnings kept the turnaround story going, as sales beat, with an assist from new partner Costco. Peloton stock neared an entry point.
Via Investor's Business Daily · February 6, 2025

Louis Bromfield won the Pulitzer Prize for his novel "Early Autumn." But he was just getting started on his life of success.
Via Investor's Business Daily · February 6, 2025

Royal Gold hit an all-time high earlier than the rest of the gold pack, topping on Oct. 21 last year. It rising toward a fresh high again.
Via Investor's Business Daily · February 6, 2025

On Wednesday, precious metal Gold Field stock received an upgrade to its Relative Strength (RS) Rating, from 70 to 73.
Via Investor's Business Daily · February 5, 2025

AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.
Via Investor's Business Daily · February 6, 2025

Bristol Myers Squibb stock tumbled Thursday on a light outlook for 2025 following a strong fourth-quarter report.
Via Investor's Business Daily · February 6, 2025

Amazon stock is likely to be moved by however the AWS cloud business performs in the company's Q4 results, which are due late Thursday.
Via Investor's Business Daily · February 6, 2025

Roblox stock collapsed after the online gaming and social platform missed estimates for users and bookings in the fourth quarter.
Via Investor's Business Daily · February 6, 2025

The company won three FDA approvals over the past two years. Now, it's angling for two new approvals in 2025.
Via Investor's Business Daily · February 6, 2025

The Dow software giant named Robin Washington, as its new CFO and COO.
Via Investor's Business Daily · February 6, 2025

The Ford earnings report follows General Motors' strong outlook.
Via Investor's Business Daily · February 5, 2025

Brazilian jet maker Embraer set for breakout, rally to 17-year highs after landing a $7 billion aircraft order from Flexjet.
Via Investor's Business Daily · February 5, 2025

Fiserv, New York Times and Performance Foods reported early.
Via Investor's Business Daily · February 5, 2025

Eli Lilly earnings beat Q4 views with 2025 guidance above consensus, even though Zepbound and Mounjaro slightly missed. Eli Lilly stock rose.
Via Investor's Business Daily · February 6, 2025

Viking Therapeutics stock plunged late Wednesday on an earnings report that included mostly incremental updates.
Via Investor's Business Daily · February 5, 2025

Meta stock has closed higher on 13 straight days, continuing its longest-ever winning streak as investors cheer the Facebook owner's AI plans.
Via Investor's Business Daily · February 5, 2025

Arm Holdings beat estimates for the chip designer's fiscal third quarter but offered in-line guidance. Arm stock fell on the news.
Via Investor's Business Daily · February 5, 2025

DXC Technology stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 70 to 74.
Via Investor's Business Daily · February 5, 2025

AMD stock plunged after the chipmaker reported weaker-than-expected sales of chips for artificial intelligence data centers.
Via Investor's Business Daily · February 5, 2025

MicroStrategy went on a 12-week bitcoin buying spree ahead of results.
Via Investor's Business Daily · February 5, 2025

In after-hours trades, Amgen stock fell around 2% following its fourth-quarter beat.
Via Investor's Business Daily · February 4, 2025

Google stock fell on Q4 results. Amazon earnings due Wednesday. Analysts are focused on capital spending and cloud computing growth.
Via Investor's Business Daily · February 5, 2025

Temu parent company PDD stock pared its losses after USPS said it would resume accepting packages from China after a brief pause.
Via Investor's Business Daily · February 5, 2025

Workday stock climbed after the enterprise software maker announced a restructuring that will reduce its workforce by 9%, or 1,750 employees.
Via Investor's Business Daily · February 5, 2025

GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 billion in sales.
Via Investor's Business Daily · February 5, 2025

Boston Scientific stock dipped Wednesday, but the medtech company beat Wall Street's fourth-quarter forecasts.
Via Investor's Business Daily · February 5, 2025

The company guided to 16% to 24% constant-currency sales growth in 2025.
Via Investor's Business Daily · February 5, 2025

Tuesday afternoon Dave traded at nearly 98, up more than 7% for the day. Look for the stock to break out in volume at least 40% above average.
Via Investor's Business Daily · February 4, 2025

The alternative asset managers raised dividends.
Via Investor's Business Daily · February 4, 2025

A grand bargain would likely involve AI chips. But a full breakdown could still occur.
Via Investor's Business Daily · February 5, 2025

Taking a look at top and bottom line numbers, the company has posted rising EPS and sales growth in each of the last five reports.
Via Investor's Business Daily · February 5, 2025

Analysts project Amazon EPS will pop 49% this quarter as sales hit a record $187.3 billion. It's one of 17 adds to IBD stock lists Tuesday.
Via Investor's Business Daily · February 4, 2025

Chipmaker AMD beat estimates for the fourth quarter and guided higher than views for the current period. But AMD stock fell after the report.
Via Investor's Business Daily · February 4, 2025

Google stock tumbled after parent Alphabet reported Q4 earnings that met consensus estimates while revenue came in slightly below views.
Via Investor's Business Daily · February 4, 2025

Viavi Solutions stock had its Relative Strength (RS) Rating upgraded to 93 Tuesday, up from 78 a day earlier.
Via Investor's Business Daily · February 4, 2025

Uber stock is off to a strong start in 2025 after a down year. The ride-hail firm reports Q4 results early Wednesday.
Via Investor's Business Daily · February 4, 2025

RFK Jr. cleared a key hurdle Tuesday after the Senate Finance Committee voted along party lines in favor of his nomination.
Via Investor's Business Daily · February 4, 2025

Snapchat parent company Snap will report fourth quarter earnings later today. Snap stock was gaining ahead of the report.
Via Investor's Business Daily · February 4, 2025

Disney reports Q1 results Wednesday. The Dow giant inked a sports streaming deal.
Via Investor's Business Daily · February 4, 2025

Cost inflation, Trump tariffs and avocado prices are all key items to watch during the Chipotle earnings report.
Via Investor's Business Daily · February 4, 2025

On Palantir's Q4 earnings call, CTO Shyam Sankar commented on the sudden emergence of Chinese startup DeepSeek.
Via Investor's Business Daily · February 4, 2025

Amazon stock has held up despite tariff concerns, and DeepSeek roiling tech stocks. Its Q4 results due Thursday offer a big test.
Via Investor's Business Daily · February 4, 2025

Adobe continues to release new generative AI features for its software products at a rapid pace. But Adobe stock is still in the doghouse.
Via Investor's Business Daily · February 4, 2025

Regeneron stock rose early Tuesday on a strong fourth-quarter report that included in-line sales of eye drug Eylea.
Via Investor's Business Daily · February 4, 2025